Ultrasound-guided fine-needle aspiration of clinically negative lymph nodes versus sentinel node mapping in patients at high risk for axillary metastasis

Annals of Surgical Oncology

Volumn 13, Issue 12, 2006, Pages 1545-1552

  Davis, Joseph T ^a   Brill, Yolanda M ^a   Simmons, Sam ^a   Sachleben, Brant C ^a   Cibull, Michael L ^a   McGrath, Patrick ^a   Wright, Heather ^a   Romond, Edward ^a   Hester, Molly ^a   Moore, Angela ^a   Samayoa, Luis M ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b LEXINGTON VA MEDICAL CENTER   (United States)

Author keywords

Breast cancer; High risk patients; Sentinel node; Ultrasound guided cytology

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; AXILLARY LYMPH NODE; BREAST TUMOR; CANCER DIAGNOSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CYTODIAGNOSIS; DISSECTION; ECHOGRAPHY; ECHOMAMMOGRAPHY; HEALTH CARE COST; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; PATHOLOGY; PROSPECTIVE STUDY; RADIODIAGNOSIS; SENTINEL LYMPH NODE BIOPSY; ULTRASOUND;

AXILLA; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY;

EID: 33845602134     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9095-8     Document Type: Article

References (26)

1. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 2006; 106:4-16.
2. Hill AD, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999; 229:528-35.
3. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999; 91:368-73.
4. Winchester DJ, Sener SF, Winchester DP, et al. Sentinel lymphadenectomy for breast cancer: experience with 180 consecutive patients - efficacy of filtered technetium 99m sulphur colloid with overnight migration time. J Am Coll Surg 1999; 188:597-603.
5. Tanis PJ, van Sandick JW, Nieweg OE, et al. The hidden sentinel node in breast cancer. Eur J Nucl Med Mol Imaging 2002; 29:305-11.
6. Rutledge H, Davis J, Chiu R, et al. Sentinel node micrometastasis in breast carcinoma may not be an indication for complete axillary dissection. Mod Pathol 2005; 18:762-8.
7. Weiser MR, Montgomery LL, Tan LK, et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 2001; 8:145-9.
8. Degnim AC, Griffith KA, Sabel MS, et al. Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer 2003; 98:2307-15.
9. Abdessalam SF, Zervos EE, Prasad M, et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 2001; 182:316-20.
10. Bedrosian I, Bedi D, Kuerer HM, et al. Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol 2003; 10:1025-30.
11. Bonnema J, van Geel AN, van Ooijen B, et al. Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic method. World J Surg 1997; 21:270-4.
12. Damera A, Evans AJ, Cornford EJ, et al. Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer. Br J Cancer 2003; 89:1310-3.
13. de Kanter AY, van Eijck CH, van Geel AN, et al. Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg 1999; 86:1459-62.
14. Deurloo EE, Tanis PJ, Gilhuijs KG, et al. Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer 2003; 39:1068-73.
15. Krishnamurthy S, Sneige N, Bedi DG, et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 2002; 95:982-8.
16. Vaidya JS, Vyas JJ, Thakur MH, et al. Role of ultrasonography to detect axillary node involvement in operable breast cancer. Eur J Surg Oncol 1996; 22:140-3.
17. Verbanck J, Vandewiele I, De Winter H, et al. Value of axillary ultrasonography and sonographically guided puncture of axillary nodes: a prospective study in 144 consecutive patients. J Clin Ultrasound 1997; 25:53-6.
18. Yang WT, Ahuja A, Tang A, et al. High resolution sonographic detection of axillary lymph node metastases in breast cancer. J Ultrasound Med 1996; 15:241-6.
19. van Rijk MC, Deurloo EE, Nieweg OE, et al. Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy. Ann Surg Oncol 2006; 13:31-5.
20. Elston C. Grading of invasive carcinoma of the breast. (1987) In: Page D, Anderson T, eds. Diagnostic Histopathology of the Breast. New York: Churchill Livingston, pp 300-11.
21. Stavros T. (2003) Evaluation of regional lymph nodes in breast cancer patients. In: Breast Ultrasound. Philadelphia: Lippincott Williams & Wilkins, pp 855-64.
22. Cox CE, Yeatman T, Salud CJ, Bass SS. Significance of sentinel node micrometastasis. Cancer Control 1999; 6:601-5.
23. den Bakker MA, van Weeszenberg A, de Kanter AY, et al. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J Clin Pathol 2002; 55:932-5.
24. Oruwari JU, Chung MA, Koelliker S, et al. Axillary staging using ultrasound-guided fine needle aspiration biopsy in locally advanced breast cancer. Am J Surg 2002; 184:307-9.
25. Khan A, Sabel MS, Nees A, et al. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy. Ann Surg Oncol 2005; 12:697-704.
26. Rouzier R, Extra JM, Klijanienko J, et al. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol 2002; 20:1304-10.